Intrinsic Value of S&P & Nasdaq Contact Us

Syros Pharmaceuticals, Inc. SYRS OTC

Other OTC • Healthcare • Biotechnology • US • USD

SharesGrow Score
35/100
1/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$16.67
+4762757.1%

Syros Pharmaceuticals, Inc. (SYRS) — Analyst outlook / Analyst consensus target is. Based on 9 analyst ratings, the consensus is bullish — 4 Buy, 5 Hold.

The consensus price target is $16.67 (low: $5.00, high: $30.00), representing an upside of 4762757.1% from the current price $0.00.

SYRS Stock — 12-Month Price Forecast

$16.67
▲ +4,762,757.14% Upside
Average Price Target
Based on 9 Wall Street analysts offering 12-month price targets for Syros Pharmaceuticals, Inc., the average price target is $16.67, with a high forecast of $30.00, and a low forecast of $5.00.
The average price target represents a +4,762,757.14% change from the last price of $0.00.
Highest Price Target
$30.00
Average Price Target
$16.67
Lowest Price Target
$5.00

SYRS Analyst Ratings

Hold
9
Ratings
4 Buy
5 Hold
Based on 9 analysts giving stock ratings to Syros Pharmaceuticals, Inc. in the past 3 months
Rating breakdown
Buy
4 44%
Hold
5 56%
44%
Buy
4 analysts
56%
Hold
5 analysts
0%
Sell
0 analysts
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message